⌘K

Login Start Free

Home/Filings/4/0001808805-21-000031

4//SEC Filing

Mallick Parag 4

Accession 0001808805-21-000031

CIK 0001808805other

View on SEC.gov Company Profile

Filed

Dec 20, 7:00 PM ET

Accepted

Dec 21, 5:40 PM ET

Size

4.7 KB

Accession

0001808805-21-000031

Insider Transaction Report

Form 4

Period: 2021-12-21

Nautilus Biotechnology, Inc.NAUT

DirectorChief Scientist10% Owner

Transactions

Gift
Common Stock
2021-12-21−210,000→ 20,479,892 total

Documents

1 file

4
wf-form4_164012641147342.xmlPrimary
FORM 4

Issuer

Nautilus Biotechnology, Inc.

CIK 0001808805

Entity typeother

Related Parties

1

filerCIK 0001857948

Filing Metadata

Form type: 4
Filed: Dec 20, 7:00 PM ET
Accepted: Dec 21, 5:40 PM ET
Size: 4.7 KB

View on SEC.gov